0001104659-24-132525.txt : 20241230 0001104659-24-132525.hdr.sgml : 20241230 20241230164644 ACCESSION NUMBER: 0001104659-24-132525 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241230 DATE AS OF CHANGE: 20241230 EFFECTIVENESS DATE: 20241230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-533696 FILM NUMBER: 241590356 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE BCM-A, MS: BCM251 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE BCM-A, MS: BCM251 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 D 1 primary_doc.xml X0708 D LIVE 0001094038 Marker Therapeutics, Inc. 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX TEXAS 77021 713-400-6400 DELAWARE None TAPIMMUNE INC. TAPIMMUNE INC GENEMAX CORP Corporation true Juan Vera 2450 Holcombe Blvd Suite BCM-A, MS: BCM251 Houston TX TEXAS 77021 Executive Officer Director David Eansor 2450 Holcombe Blvd Suite BCM-A, MS: BCM251 Houston TX TEXAS 77021 Director John Wilson 2450 Holcombe Blvd Suite BCM-A, MS: BCM251 Houston TX TEXAS 77021 Director Katharine Knobil 2450 Holcombe Blvd Suite BCM-A, MS: BCM251 Houston TX TEXAS 77021 Director Steven Elms 2450 Holcombe Blvd Suite BCM-A, MS: BCM251 Houston TX TEXAS 77021 Director Biotechnology Decline to Disclose 06b false 2024-12-23 false true true false 100000 CANACCORD GENUITY LLC 000001020 None None ONE PENNSYLVANIA PLAZA SUITE 2900 New York NY NEW YORK 10119 DE DELAWARE MD MARYLAND NY NEW YORK false Brookline Capital Markets, a division of Arcadia Securities, LLC 000044656 None None 1370 Avenue of the Americas 29th Floor New York NY NEW YORK 10019 DE DELAWARE MD MARYLAND NY NEW YORK false 16100000 16100000 0 false 5 816000 0 0 false Marker Therapeutics, Inc. /s/ Juan Vera Juan Vera Chief Executive Officer 2024-12-30